Background and aims: Variations in inotrope changeover technique can contribute to deviations in blood pressure, heart rate, internal bleeding and in extremis, death (Sheppard, 2001; Crisp, 2002; ...
Reduction in the frequency of hospitalizations, by delaying additional episodes of acute decompensated heart failure; and Weaning patients with severe heart failure who are currently dependent on ...
Leanne Llewellyn, BSc, RN, is a sister in the paediatric intensive care unit, King’s College Hospital NHS Foundation Trust, London Most inotrope infusions are delivered via an infusion pump in order ...
Toronto, ON - An investigational oral inotropic agent, a selective inhibitor of phosphodiesterase-3 (PDE-3), took a small, uncertain step forward when a randomized, placebo-controlled trial showed it ...
Against expectations, critically ill people in cardiogenic shock fared similarly receiving one widely used inotrope or another in the small DOREMI trial. Patients had the same clinical outcomes on ...
For critically ill people with acute cardiogenic shock on advanced mechanical life support, IV levosimendan came up short when tested in a modest-sized randomized trial. The calcium-sensitizing ...
Leanne Llewellyn, BSc, RN, is a sister in the paediatric intensive care unit, King’s College Hospital NHS Foundation Trust, London Most inotrope infusions are delivered via an infusion pump in order ...
French centers tested the calcium-sensitizing inotrope levosimendan in patients with severe but potentially reversible cardiogenic shock recently put on VA-ECMO. Early levosimendan did not facilitate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results